Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008:1:83-91.
doi: 10.4137/cpath.s667. Epub 2008 Jul 28.

Commonality between diabetes and Alzheimer's disease and a new strategy for the therapy

Li Lin  1
Affiliations

Commonality between diabetes and Alzheimer's disease and a new strategy for the therapy

Li Lin. Clin Med Pathol. 2008.
No abstract available

Keywords: Alzheimer’s disease; diabetes; glucagon-like peptide 1.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Common pathological processes in AD and T2DM. Ninety percent homologous structure was shown between Aβ which is a hallmark pathology in AD and IAPP which is involved in T2DM. Insulin abnormality is attributed to AD by promoting Aβ deposite, and τ protein hyperphosphorylation. GSK3 is a key kinase to promoteτ protein hyperphosphorylation and glycogen biosynthesis. Abbreviations: AD: Alzheimer’s disease; T2DM: Type 2 diabetes mellitus; IAPP: islet amyloid polypeptide; Aβ: Amyloid β; GSK3: glycogen synthase kinase.
See this image and copyright information in PMC

References

    1. Li L, Holscher C. Common pathological processes in Alzheimer disease and type 2 diabetes: A review. Brain Res Rev. 2007;56:384–402. - PubMed
    1. Haan MN. Therapy Insight: type 2 diabetes mellitus and the risk of late-onset Alzheimer’s disease. Nature Clinical Practice Neurology. 2006;2:159–66. - PubMed
    1. Xu WL, Qiu CX, Wahlin A, Winblad B, Fratiglioni L. Diabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up study. Neurology. 2004;63:1181–6. - PubMed
    1. Luchsinger JA, Tang MX, Shea S, Mayeux R. Hyper-insulinemia and risk of Alzheimer disease. Neurology. 2004;63:1187–92. - PubMed
    1. Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM. Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology. 1999;53:1937–42. - PubMed

LinkOut - more resources